Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05754840 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CANnabinoids in Pediatric ONCology

Study acronym: CAN-PONC
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 3
    • Primary and study completion dates: Mar 31, 2027 to Dec 31, 2026
    • Start date changed from estimate of Jun 2025 to Jul 18, 2025
    v4
  2. Primary and study completion dates: Dec 2025 to Mar 31, 2027
    • Start date: Mar 2024 to Jun 2025
    • Eligibility criteria expanded, about 39 words
    • Collaborators: 3 to 2
    v3
  3. Start date: Jun 2023 to Mar 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial looking at the tolerability of cannabinoids in children with cancer across 3 Canadian children's hospitals.
Trial Details
NCT Number NCT05754840
Lead Sponsor University of Manitoba
Collaborators: Canadian Cancer Society (CCS), Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Childhood Cancer, Cancer
Related terms Marijuana Abuse, Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov